Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...

Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

WESTFIELD - The adage of “don’t let limitations confine you” is one that Irene Lansing embodies on a daily basis.

Chronic obstructive pulmonary disease (COPD), a significant yet often overlooked health issue in Malaysia due to low awareness and understanding, affects a considerable portion of the population, as ...

Mild to moderate COPD with vs without emphysema is associated with significantly worse HRQOL, but similar lung function decline.

Higher dietary magnesium intake is associated with a reduced risk of frailty in patients with chronic obstructive pulmonary ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...

British drug maker GSK plc (GSK, GSK.L) announced Monday that the U.S. Food and Drug Administration has accepted for review, data ...